Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Dyslipidemia

  Free Subscription


19.12.2011

3 Am Heart J
1 Ann Pharmacother
6 Atherosclerosis
2 Circulation
1 Clin Cardiol
1 Hypertension
4 J Clin Endocrinol Metab
1 J Neurol
5 JAMA
1 Metabolism
1 N Engl J Med


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. VIRANI SS , Woodard LD, Chitwood SS, Landrum CR, et al
    Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease.
    Am Heart J. 2011;162:725-732.
    PubMed     Text format     Related articles    Abstract available


  2. DANSKY HM , Bloomfield D, Gibbons P, Liu S, et al
    Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia.
    Am Heart J. 2011;162:708-16.
    PubMed     Text format     Related articles    Abstract available


  3. KELLY DJ , Gershlick T, Witzenbichler B, Guagliumi G, et al
    Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial.
    Am Heart J. 2011;162:663-70.
    PubMed     Text format     Related articles    Abstract available



    Ann Pharmacother

  4. YOON HS , Kim SH, Kim JK, Ko SH, et al
    Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Ann Pharmacother. 2011;45.
    PubMed     Text format     Related articles    Abstract available



    Atherosclerosis

  5. DESCAMPS OS , De Sutter J, Guillaume M, Missault L, et al
    Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
    Atherosclerosis. 2011;217:308-21.
    PubMed     Text format     Related articles    Abstract available


  6. PETERS BJ , Pett H, Klungel OH, Stricker BH, et al
    Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.
    Atherosclerosis. 2011;217:458-64.
    PubMed     Text format     Related articles    Abstract available


  7. HOFNAGEL O , Engel T, Severs NJ, Robenek H, et al
    SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion.
    Atherosclerosis. 2011;217:371-8.
    PubMed     Text format     Related articles    Abstract available


  8. YUNOKI K , Nakamura K, Miyoshi T, Enko K, et al
    Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
    Atherosclerosis. 2011;217:486-91.
    PubMed     Text format     Related articles    Abstract available


  9. LEE M , Saver JL, Towfighi A, Chow J, et al
    Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis.
    Atherosclerosis. 2011;217:492-8.
    PubMed     Text format     Related articles    Abstract available


  10. HADDAD P , Dussault S, Groleau J, Turgeon J, et al
    Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: Effects on endothelial progenitor cells and mature endothelial cells.
    Atherosclerosis. 2011.
    PubMed     Text format     Related articles   



    Circulation

  11. RUTHERFORD JD
    Maternal heterozygous familial hypercholesterolemia and its consequences for mother and child.
    Circulation. 2011;124:1599-601.
    PubMed     Text format     Related articles   


  12. TOLEIKYTE I , Retterstol K, Leren TP, Iversen PO, et al
    Pregnancy Outcomes in Familial Hypercholesterolemia: A Registry-Based Study.
    Circulation. 2011.
    PubMed     Text format     Related articles    Abstract available



    Clin Cardiol

  13. YANG Q , Lu S, Chen Y, Song X, et al
    Plasma Osteoprotegerin Levels and Long-Term Prognosis in Patients With Intermediate Coronary Artery Lesions.
    Clin Cardiol. 2011 Jun 15. doi: 10.1002/clc.20909.
    PubMed     Text format     Related articles    Abstract available



    Hypertension

  14. ROMAN MJ , Howard BV, Howard WJ, Mete M, et al
    Differential Impacts of Blood Pressure and Lipid Lowering on Regression of Ventricular and Arterial Mass: The Stop Atherosclerosis in Native Diabetics Trial.
    Hypertension. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Clin Endocrinol Metab

  15. OOI EM , Watts GF, Sprecher DL, Chan DC, et al
    Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-{delta} Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available


  16. CHARRIERE S , Peretti N, Bernard S, Di Filippo M, et al
    GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
    J Clin Endocrinol Metab. 2011;96:E1675-9.
    PubMed     Text format     Related articles    Abstract available


  17. FRERIKS K , Timmermans J, Beerendonk CC, Verhaak CM, et al
    Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome.
    J Clin Endocrinol Metab. 2011;96:E1517-26.
    PubMed     Text format     Related articles    Abstract available


  18. BAYS HE , Schwartz S, Littlejohn T 3rd, Kerzner B, et al
    MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.
    J Clin Endocrinol Metab. 2011;96:2889-97.
    PubMed     Text format     Related articles    Abstract available



    J Neurol

  19. RENARD D , Rougier M, Aichoun I, Labauge P, et al
    Hyoid bone-related focal carotid vasculopathy.
    J Neurol. 2011;258:1540-1.
    PubMed     Text format     Related articles   



    JAMA

  20. WEINGARTNER O , Bohm M, Laufs U
    Cholesterol-lowering foods and reduction in serum cholesterol levels.
    JAMA. 2011;306:2217-8.
    PubMed     Text format     Related articles   


  21. PETERSON ED , Gaziano JM
    Cardiology in 2011--amazing opportunities, huge challenges.
    JAMA. 2011;306:2158-9.
    PubMed     Text format     Related articles   


  22. CANTO JG , Kiefe CI, Rogers WJ, Peterson ED, et al
    Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction.
    JAMA. 2011;306:2120-2127.
    PubMed     Text format     Related articles    Abstract available


  23. NICHOLLS SJ , Brewer HB, Kastelein JJ, Krueger KA, et al
    Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
    JAMA. 2011;306:2099-109.
    PubMed     Text format     Related articles    Abstract available


  24. MITKA M
    Statin therapy in primary CVD prevention remains a hot-button topic for some.
    JAMA. 2011;306:2077-8.
    PubMed     Text format     Related articles   



    Metabolism

  25. VOULGARI C , Katsilambros N, Tentolouris N
    Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study.
    Metabolism. 2011.
    PubMed     Text format     Related articles    Abstract available



    N Engl J Med

  26. JUONALA M , Magnussen CG, Berenson GS, Venn A, et al
    Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors.
    N Engl J Med. 2011;365:1876-1885.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: